Forma Therapeutics Holdings, Inc.
(NASDAQ) FMTX
Forma Therapeutics Holdings, Inc. Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$190.16M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
FMTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Forma Therapeutics Holdings, Inc.
Industry
Biotechnology
Sector
Health CareEmployees
166
CEO
Frank D. Lee, MBA
Website
www.formatherapeutics.comHeadquarters
Watertown, MA 02472, US
FMTX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-30%
Return on Capital
-33%
Return on Assets
-31%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$172.81M
EBITDA
$171.24M
Operating Cash Flow
$149.79M
Capital Expenditure
$4.18M
Free Cash Flow
$153.97M
Cash & ST Invst.
$464.23M
Total Debt
$32.74M
Forma Therapeutics Holdings, Inc. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
189
N/A
Net Income
$52.58M
-20.6%
EBITDA
$51.28M
-18.4%
Quarterly Fundamentals
Net Cash
$363.36M
-31.5%
Accounts Receivable
$15.37M
+0.9%
Inventory
$0.00
N/A
Long Term Debt
$27.21M
+846.9%
Short Term Debt
$5.33M
+183.2%
Return on Assets
-30.83%
N/A
Return on Invested Capital
-32.86%
N/A
Free Cash Flow
$45.56M
-39.6%
Operating Cash Flow
$44.76M
-37.6%